GB846933A - New antifungal substance, pimaricin, and method of producing same - Google Patents

New antifungal substance, pimaricin, and method of producing same

Info

Publication number
GB846933A
GB846933A GB22627/57A GB2262757A GB846933A GB 846933 A GB846933 A GB 846933A GB 22627/57 A GB22627/57 A GB 22627/57A GB 2262757 A GB2262757 A GB 2262757A GB 846933 A GB846933 A GB 846933A
Authority
GB
United Kingdom
Prior art keywords
antibiotic
methanol
acid
acetic acid
pimaricin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB22627/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB846933A publication Critical patent/GB846933A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/626Natamycin; Pimaricin; Tennecetin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

An antifungal antibiotic pimaricinis produced by aerobically fermenting a pimaricin-producing strain of Streptomyces gilvosporeus especially S. gilvosporeus ATCC 13326 in an aqueous nutrient medium containing a source of <PICT:0846933/IV(b)/1> <PICT:0846933/IV(b)/2> carbon, nitrogen and inorganic salts. Specified carbon sources are starch, hydrolysed starch ; sugars such as lactose, maltose, dextrose, sucrose and molasses ; alcohols such as glycerol and mannitol ; organic acids such as citric acid and acetic acid. Nitrogen sources are proteins such as casein, zein and lactalbumin ; protein hydrolysates such as proteoses, peptones and peptides ; corn steep liquor, soybean meal, gluten, cotton-seed meal, fish meal, meat extracts, stick liquor, liver cake, yeast extracts, distillers solubles, amino acids, urea, ammonium and nitrates. Other additions are (a) mineral salts, e.g. sodium, potassium, calcium, magnesium, chlorides, sulphates and phosphates (b) trace elements, e.g. boron, cobalt, iron, copper, zinc, manganese, chromium and molybdenum. The pH is preferably 6 to 8, the temperature of cultivation 17 to 42 DEG C. and preferably 26 to 30 DEG C. and the duration 48 to 120 hours. The antibiotic is isolated from the broth by (a) adsorption or (b) extraction with a water-miscible polar organic solvent such as methanol, butanol, acid acetone, ethanol, propanol, dimethylformamide, pyridine, methyl ethyl ketone and ethyl acetate. The broth is adjusted to pH 7,0 and filtered with a filter aid. Magnesol (a synthetic hydrated magnesium silicate), Fuller's earth or activated charcoal is added to the filtrate, and the antibiotic eluted therefrom with a water-miscible polar organic solvent especially methanol, which is then followed by 70% aqueous methanol. The eluates are pooled, concentrated and cooled to 3-5 DEG C. The crude so formed is further purified by dissolving in glacial acetic acid, filtering and adjusting to pH 4,0 with aqueous ammonia. Alternatively, a solution in the minimum quantity of glacial acetic acid is poured into water. The sulphate is prepared by dissolving the antibiotic in glacial acetic acid, filtering and adding sulphuric acid. The picrate is prepared by adding picric acid to an ethanol solution of the antibiotic. The addition of potassium hydroxide to a methanol solution of the antibiotic leads to the production of the monopotassium salt. The N-acetyl derivative is prepared by reacting pimaricin with acetic anhydride in methanol. The anti-fungal antibiotic is a white crystalline substance with amphoteric properties forming salts with acids and with alkali metals; it contains 58% carbon, 7,5% hydrogen, 2% nitrogen and 32,5% oxygen ; free base has [a ]d25 of 248 (0,5% in dimethylformamide); N-acetyl derivative has Nx of 1,522, Ny of 1,543 \sB 0,002 and has a positive optic sign ; ultraviolet absorption spectrum has the characteristics shown in Fig. 2 and the infra-red absorption spectrum is given in Fig. 1; it is soluble in benzene, dioxane, aqueous dioxane, pyridine, piperidine, methanol, ethanol but is insoluble in ether and petroleum ether. It is distinguished from the antibiotics rimocidin and chromin (J. Antibiotics 6(5) 247-250, 1953) by paper strip chromatography using as solvent system the upper phase of a mixture of triethylamine, formamide and water 100 : 30 : 100.
GB22627/57A 1956-07-23 1957-07-17 New antifungal substance, pimaricin, and method of producing same Expired GB846933A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US846933XA 1956-07-23 1956-07-23

Publications (1)

Publication Number Publication Date
GB846933A true GB846933A (en) 1960-09-07

Family

ID=22186637

Family Applications (1)

Application Number Title Priority Date Filing Date
GB22627/57A Expired GB846933A (en) 1956-07-23 1957-07-17 New antifungal substance, pimaricin, and method of producing same

Country Status (1)

Country Link
GB (1) GB846933A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003170A1 (en) * 1991-08-05 1993-02-18 Bio-Technical Resources A fermentation process for producing natamycin
WO1993003169A1 (en) * 1991-08-05 1993-02-18 Bio-Technical Resources A fermentation process for producing natamycin
WO1993003171A1 (en) * 1991-08-05 1993-02-18 Bio-Technical Resources Continuous natamycin production
JPH07508037A (en) * 1992-05-21 1995-09-07 ザ スクリップス リサーチ インスティテュート Enantiomeric dynemycin analogues, their manufacture and use
US5591438A (en) * 1990-12-07 1997-01-07 Bio-Technical Resources L.P. Natamycin recovery
US5686273A (en) * 1991-08-05 1997-11-11 Cultor Food Science, Inc. Fermentation process for producing natamycin with additional carbon and nitrogen
US5902579A (en) * 1991-08-05 1999-05-11 Bio-Technical Resources Natamycin-containing streptomyces biomass and its use in animal feed
US5942611A (en) * 1995-01-19 1999-08-24 Cultor Ltd. Process for natamycin recovery
WO2002081717A2 (en) * 2001-04-06 2002-10-17 Asa Spezialenzyme Gmbh Production of pimaricin and pimaricin derivatives in addition to the use thereof in plant protection
CN101914123A (en) * 2010-09-27 2010-12-15 郑州奇泓生物科技有限公司 Method for recovering natamycin from waste liquid

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591438A (en) * 1990-12-07 1997-01-07 Bio-Technical Resources L.P. Natamycin recovery
WO1993003170A1 (en) * 1991-08-05 1993-02-18 Bio-Technical Resources A fermentation process for producing natamycin
WO1993003169A1 (en) * 1991-08-05 1993-02-18 Bio-Technical Resources A fermentation process for producing natamycin
WO1993003171A1 (en) * 1991-08-05 1993-02-18 Bio-Technical Resources Continuous natamycin production
US5231014A (en) * 1991-08-05 1993-07-27 Bio-Technical Resources Fermentation process for producing natamycin
US5686273A (en) * 1991-08-05 1997-11-11 Cultor Food Science, Inc. Fermentation process for producing natamycin with additional carbon and nitrogen
US5902579A (en) * 1991-08-05 1999-05-11 Bio-Technical Resources Natamycin-containing streptomyces biomass and its use in animal feed
JPH07508037A (en) * 1992-05-21 1995-09-07 ザ スクリップス リサーチ インスティテュート Enantiomeric dynemycin analogues, their manufacture and use
US5942611A (en) * 1995-01-19 1999-08-24 Cultor Ltd. Process for natamycin recovery
WO2002081717A2 (en) * 2001-04-06 2002-10-17 Asa Spezialenzyme Gmbh Production of pimaricin and pimaricin derivatives in addition to the use thereof in plant protection
WO2002081717A3 (en) * 2001-04-06 2002-12-12 Asa Spezialenzyme Gmbh Production of pimaricin and pimaricin derivatives in addition to the use thereof in plant protection
CN101914123A (en) * 2010-09-27 2010-12-15 郑州奇泓生物科技有限公司 Method for recovering natamycin from waste liquid

Similar Documents

Publication Publication Date Title
US2789118A (en) 16-alpha oxy-belta1, 4-pregnadienes
GB846933A (en) New antifungal substance, pimaricin, and method of producing same
GB1339032A (en) Rabelomycin and processes for its production
GB715362A (en) Improvements in or relating to antimicrobial agent
GB877732A (en) The antibiotic rifomycin, its components and methods of preparing same
GB846130A (en) New antibiotic and derivatives and salts thereof, preparations containing the same and process for the manufacture of these substances
GB844289A (en) Pimaricin and process of producing same
Matsuoka et al. Unamycin, an antifungal substance produced by Streptomyces fungicidicus
ES255258A1 (en) Chalcomycin and its fermentative production
GB762736A (en) The new antibiotic b-mycin and processes for its preparation
US3271386A (en) 5-amino-4-imidazolecarboxamide riboside recovery process
GB793797A (en) Improvements in or relating to antibiotics
US3975366A (en) Process for the production of new pepstatins having anti-pepsin activity
Miyaura et al. Studies on the Antibiotics from Actinomycetes. An Antibiotic Pigment from Streptomyces F-23b
GB764198A (en) The antibiotic vengicide and processes for the preparation of the antibiotics oxytetracycline and vengicide
GB758726A (en) New antibiotic and process for its preparation
GB876635A (en) Process for preparing a new antibiotic designated fi.1163
GB815381A (en) Antibiotic designated nucleocidin and preparation thereof
GB897581A (en) Preparation of a new antibiotic aspartocin
GB770065A (en) Production of tetracycline by fermentation
GB936314A (en) Tetracycline and chlortetracycline complexes
GB684417A (en) A new antibiotic and a process for the production thereof
US2833696A (en) Culture process for erythromycin a
US2693433A (en) Picromycin, its salts and the process of producing same
GB779570A (en) A new antibiotic streptolydigin